Aim: During diabetic pregnancy, complex metabolic changes occur in the lipid profile. The aim of the study was to determine the predictive values of maternal serum lipid levels on large-for-gestational age newborns during the third trimester in pregnancies of women with type 2 diabetes mellitus (DM2) and gestational diabetes mellitus (GDM).
Material and methods: Data of forty three pregnancies of women with DM2 and two hundred women with GDM were analyzed. The analysis encompassed the following parameters: age, body mass index (BMI), lipid parameters, HbA1c in first, second and third trimester of pregnancy, preeclampsia and baby birth weight.
Results: DM2 and GDM groups showed statistically significant differences in the following variables: total lipids, triglycerides, total cholesterol, BMI, age, baby birth weight, incidence of SGA and preterm delivery (9.4 ± 2.3 vs. 11.0 ± 2.3 mmol/L, 2.4 ± 1.4 vs. 3.4 ± 1.6 mmol/L, 5.5 ± 1.2 vs. 6.4 ± 1.4 mmol/L, 30.6 ± 5.4 vs. 26.9 ± 5.2 kg/m2, 34 ± 7.8 vs. 31.5 ± 5.6 years, 3183 ± 972 vs. 3533 ± 699 g., 20% vs. 7.5%, 27.9 vs. 14%, respectively, p < 0.05). Linear multiple regression analysis demonstrated that triglycerides, LDL-C and total cholesterol were independent predictors of LGA (p < 0.05).
Conclusion: Triglycerides and LDL-C in the third trimester of pregnancy are independent predictors for fetal macrosomia in DM2 and GDM pregnancies. Thus, the maternal serum triglycerides and LDL-C levels determined in the maternal blood taken in the third trimester of pregnancy may indentify women who will give birth to LGA newborns.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Horosz E Bomba Opon D Wielogos M Szymanska M Bartlkowink R. Effects of maternal lipids on the fetal growth in gestational diabetes. Neuro Endocrinol Lett. 2009; 30: 652–6.
2. Schaefer-Graf UM Meitzner K Ortega-Senovilla H Graf K Vetter K Abou-Dakan M et al. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med. 2011; 28: 1053–9.
3. Son GH Kwon JY Kim YH Park YW. Maternal serum triglycerides as predictive factors for large-for-gestational age newborns with gestational diabetes mellitus. Acta Obstet Gynecol Scand. 2010; 89: 700–4.
4. Sattar N Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening. BMJ. 2002; 325: 157–60.
5. Vahratian A Misra VK Trudeau S Misra DP. Prepregnancy body mass index and gestational age-dependent changes in lipid levels during pregnancy. Obstet Gynecol. 2010; 116: 107–13.
6. Koukkou E Watts GF Lowy C. Serum lipid lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study. J Clin Pathol. 1996; 49: 634–7.
7. Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes. 1980; 29: 1023–35.
8. Smolarczyk R Czajkowski K Wójcicka-Jagodziñska J et al. The influence of chosen hormones on lipids and its correlation during normal pregnancy. Gin Pol. 2001; 10:765–71.
9. Barrett HL Nitert MD McIntyre HD Callaway LK. Normalizing metabolism in diabetic pregnancy: is it time to target lipids? Diabetes Care. 2014; 37(5): 1484–93.
10. Gobi CS Handisurya A Klein K Bozkurt L Luger A Bancher-Todesca D et al. Changes in serum lipid levels during pregnancy in type 1 and type 2 diabetic subjects. Diabetes Care. 2010; 33: 2071–73.
11. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33: 676–82.
12. Simeonova Krstevska S Krstevska B Velkoska Nakova V Hagji-Lega M Samargjiski I Serafimoski V et al. Effect of lipid parameters on foetal growth in gestational diabetes mellitus pregnancies. Contributions Section of Medical Sciences. 2014; XXXV2 10.
13. Kulkarni SR Kumaran K Rao SR Chougule SD Deokar TM Bhalerao AJ et al. Maternal lipids are as important as glucose for fetal growth: findings from the Pune Maternal Nutrition Study. Diabetes Care. 2013; 36(9): 2706–13.
14. Kitajima M Oka S Yasuhi IFM Rii Y Ishimaru T. Maternal serum triglyceride at 24–32 weeks’ gestation and newborn weight in non diabetic women with positive diabetic screens. Obstet Gynecol. 2001; 97: 776–80.
15. Knopp RH Magee MS Walden CE Bonet B Benedetti TJ. Prediction of infant birth weight by GDM screening: importance of triglyceride. Diabetes Care. 1992; 15: 1605–13.
16. Schaefer – Graf U Graf K Kulbacka I Kjos SL Dudenhausen J Velter KE et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care. 2008; 17: 97–103.
17. Yang YD Zhai GR Yang HX. Factors relevant to Newborn birth weight in pregnancy complicated with abnormal glucose metabolism. Department of Obstetrics and Gynecology Peking University First Hospital Beijing 10003 China. 2000; 45(9): 646–51.
18. National Cholesterol Education Program. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood cholesterol in Adults (Adult Treatment Panel III). Final report 2002.
19. Krstevska B Mishevska S Janevska E Simeonova S Livrinova V Pemovska G et al. Gestational Diabetes Mellitus- The impact of maternal body mass index and glycaemic control on baby’s birth weight (2009). Contributions Sec. Biol. Med. Sci. MASA XXX 2009(2): 115–24.
20. Krstevska B Velkoska Nakova V Adamova G Simeonova S Dimitrovski Ch Livrinova V et al. Association between foetal growth and different maternal metabolic characteristics in women with gestational diabetes mellitus. (2009): Contributions Sec. Biol. Med. Sci. MASA XXX 2009(2): 103–14.